Fig. 1.
Fig. 1. hP2X1 overexpression in transgenic mouse platelets. / (A) RT-PCR performed on total RNA extracted from platelets or total leukocytes (WBCs) of wild-type (WT) or transgenic (TG) mice. Identical results were found for 2 independent transgenic founder lines. Partial sequences of the human and mouse P2X1 cDNAs are shown. Primers used to specifically amplify the hP2X1 and mP2X1 cDNAs are underlined and in boldface type. The translation initiation codon is boxed. (B) Western blotting detection of the hP2X1 protein in TG platelet whole-cell lysate with a polyclonal anti-hP2X1 antibody.12 The hP2X1 expression levels in identical numbers of platelets from heterozygous or homozygous transgenic mice originating from 2 independent transgenic founder lines (TG16 and TG18) are shown in parallel with those of the endogenous mP2X1 detected in WT mouse platelets.

hP2X1 overexpression in transgenic mouse platelets.

(A) RT-PCR performed on total RNA extracted from platelets or total leukocytes (WBCs) of wild-type (WT) or transgenic (TG) mice. Identical results were found for 2 independent transgenic founder lines. Partial sequences of the human and mouse P2X1 cDNAs are shown. Primers used to specifically amplify the hP2X1 and mP2X1 cDNAs are underlined and in boldface type. The translation initiation codon is boxed. (B) Western blotting detection of the hP2X1 protein in TG platelet whole-cell lysate with a polyclonal anti-hP2X1 antibody.12 The hP2X1 expression levels in identical numbers of platelets from heterozygous or homozygous transgenic mice originating from 2 independent transgenic founder lines (TG16 and TG18) are shown in parallel with those of the endogenous mP2X1 detected in WT mouse platelets.

Close Modal

or Create an Account

Close Modal
Close Modal